Researchers presented the findings of a phase 2 trial investigating a novel subretinal gene therapy for the treatment of ...

Nanoscope Therapeutics Inc., a biotechnology company focused on developing and commercializing novel, disease‑agnostic therapies for patients with photoreceptor loss and vision impairment due to ...

Failure to notify the agency could result in a £1,000 fine and potential prosecution ...

Ethiraj College in Chennai grants a full scholarship to visually impaired student J. Kaviya for her undergraduate studies.

Married couple Javi Lorenzo Sol and Núria Martí-Andrés will be running the Edinburgh Marathon as a sighted guide running team ...

Alvin “AJ” Buckley Jr., a student at the Mississippi School for the Blind juggles wrestling and music while looking to the ...

Entered into an asset purchase agreement with Johnson & Johnson* (J&J) to acquire all interests in botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP) ...

Opus Genetics Virtual R&D Science Forum Scheduled for Tuesday, June 16, 2026, at 10:00 am ETUpcoming Data Readout for Cohort 1 of OPGx-BEST1 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. MCO-010 yielded sustained vision improvements in ...

Kiora Pharmaceuticals (NASDAQ: KPRX) today reported financial results for the first quarter ended March 31, 2026, and provided an update on its ...

LONDON and CAMBRIDGE, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (Beacon Therapeutics or the Company), a leading clinical-stage biotechnology company with a mission ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...